DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION (EIN 131980503) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1961

Legal Domicile

Principal Officer

CAROL LEE

Phone

6092081888

Tax Period

2023-11-01 to 2024-10-31

DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION, founded in 1961, is a community nonprofit that reported $5.9M in total revenue in fiscal year 2023. The organization ran a surplus of $1.2M, a strong 20% operating margin.

Mission

TO SUPPORT THE BUSINESS DEVELOPMENT OBJECTIVES OF ITS MEMBERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $5,709,392

Investment Income $225,129

Other Revenue $10,766

TOTAL REVENUE $5,945,287

Expense Breakdown

Grants Paid $25,000

Salaries & Benefits $1,676,425

Fundraising Expenses $0

Other Expenses $3,042,048

TOTAL EXPENSES $4,743,473

Year-over-Year Comparison

	2023	2022	Change
Revenue	$5,945,287	$5,604,025	+0.1%
Expenses	$4,743,473	$4,288,341	+0.1%
Net Income	$1,201,814	$1,315,684	-0.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$119,827

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Margaret Timony	Advisor to Executive Director	37.0	Highest	$335,066	$25,017	$360,083
Melissa Schultea	Deputy Director	40.0	Highest	$180,995	$9,877	$190,872
Patricia Van Arnum	Editorial Director	40.0	Highest	$119,157	$24,400	$143,557
Lauryn Kuna	Director of Member Services	40.0	Highest	$122,473	$6,653	$129,126
Miriam O'Donnell	Director of Technology	40.0	Highest	$111,139	$17,916	$129,055
Carol Lee	Executive Director	40.0	Officer	$98,013	$21,814	$119,827
CHARLES DAVIES	PRESIDENT	2.0	Officer Director	$0	$0	$0
DONNA GRUOL	1ST V. PRESIDENT	2.0	Officer Director	$0	$0	$0
Kelsey Achenbach	2nd V. President	2.0	Officer Director	$0	$0	$0
Kenneth Seufert	3rd V. President	2.0	Officer Director	$0	$0	$0
Kerri Mccullough Wood	Immediate Past President	2.0	Director	$0	$0	$0
Sean Diver	2nd Immediate Past President	2.0	Director	$0	$0	$0
Camraon Aslam	Director	2.0	Director	$0	$0	$0
Christopher Conway	Director	2.0	Director	$0	$0	$0
Craig Douglas	Director	2.0	Director	$0	$0	$0
Pierfrancesco Morosini	director	2.0	Director	$0	$0	$0
Courtney Stanton	Director	2.0	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$5,945,287	$4,743,473	$9,760,385	$1,201,814
2023	$5,604,025	$4,288,341	$7,492,601	$1,315,684
2022	$4,118,876	$3,649,686	$6,347,497	$469,190
2021	$2,350,712	$1,754,348	$7,404,869	$596,364
2020	$2,085,976	$2,257,469	$6,336,316	$-171,493
2019	$4,354,304	$4,039,427	$5,339,501	$314,877
2018	$4,530,305	$4,093,859	$4,491,270	$436,446

DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION